Aspirin as a Promising Agent for Decreasing Incidence of Cerebral Aneurysm Rupture
Authors:
- David M. HasanDHDavid M. Hasan
- James C. TornerJTJames C. Torner
- for the International Study of Unruptured Intracranial Aneurysms InvestigatorsFIfor the International Study of Unruptured Intracranial Aneurysms Investigators
- 1 November 2011
- journal article
- research article
- Published by Wolters Kluwer Health in Stroke
- Vol. 42 (11) , 3156-3162
Abstract
Background and Purpose—: Chronic inflammation is postulated as an important phenomenon in intracranial aneurysm wall pathophysiology. This study was conducted to determine if aspirin use impacts the occurrence of intracranial aneurysm rupture. Methods—: Subjects enrolled in the International Study of Unruptured Intracranial Aneurysms (ISUIA) were selected from the prospective untreated cohort (n=1691) in a nested case–control study. Cases were subjects who subsequently had a proven aneurysmal subarachnoid hemorrhage during a 5-year follow-up period. Four control subjects were matched to each case by site and size of aneurysm (58 cases, 213 control subjects). Frequency of aspirin use was determined at baseline interview. Aspirin frequency groups were analyzed for risk of aneurysmal hemorrhage. Bivariable and multivariable analyses were performed using conditional logistic regression. Results—: A trend of a protective effect for risk of unruptured intracranial aneurysm rupture was observed. Patients who used aspirin 3× weekly to daily had an OR for hemorrhage of 0.40 (95% CI, 0.18–0.87); reference group, no use of aspirin), patients in the “< once a month” group had an OR of 0.80 (95% CI, 0.31–2.05), and patients in the “> once a month to 2×/week” group had an OR of 0.87 (95% CI, 0.27–2.81; P =0.025). In multivariable risk factor analyses, patients who used aspirin 3 times weekly to daily had a significantly lower odds of hemorrhage (adjusted OR, 0.27; 95% CI, 0.11–0.67; P =0.03) compared with those who never take aspirin. Conclusions—: Frequent aspirin use may confer a protective effect for risk of intracranial aneurysm rupture. Future investigation in animal models and clinical studies is needed.Keywords
This publication has 26 references indexed in Scilit:
- PGE2‐EP2 signalling in endothelium is activated by haemodynamic stress and induces cerebral aneurysm through an amplifying loop via NF‐κBBritish Journal of Pharmacology, 2011
- Remodeling of Saccular Cerebral Artery Aneurysm Wall Is Associated With RuptureStroke, 2004
- Aspirin inhibits monocyte chemoattractant protein-1 and interleukin-8 expression in TNF-α stimulated human umbilical vein endothelial cellsAtherosclerosis, 2004
- Unruptured intracranial aneurysms: natural history, clinical outcome, and risks of surgical and endovascular treatmentThe Lancet, 2003
- Stroke epidemiology: a review of population-based studies of incidence, prevalence, and case-fatality in the late 20th centuryThe Lancet Neurology, 2003
- International Subarachnoid Aneurysm Trial (ISAT) of neurosurgical clipping versus endovascular coiling in 2143 patients with ruptured intracranial aneurysms: a randomised trialThe Lancet, 2002
- Inflammation and Intracranial AneurysmsNeurosurgery, 1999
- Sudden death from aneurysmal subarachnoid hemorrhageNeurology, 1995
- Aspirin Inhibits Nuclear Factor–κB Mobilization and Monocyte Adhesion in Stimulated Human Endothelial CellsCirculation, 1995
- Clinical course of spontaneous subarachnoid hemorrhageNeurology, 1993